Initiating tocilizumab, with or without methotrexate, compared with starting methotrexate with prednisone within step-up treatment strategies in early rheumatoid arthritis: an indirect comparison of effectiveness and safety of the U-Act-Early and CAMERA-II treat-to-target trials.
Maxime M A VerhoevenMarjolein Jh de HairJanneke TekstraJohannes Wj BijlsmaJacob M van LaarAttila Pethoe-SchrammMichelle Ea BormEvert-Jan Ter BorgSuzanne P Linn-RaskerXavier M TeitsmaFloris Pjg LafeberJohannes Wg JacobsPaco Mj WelsingPublished in: Annals of the rheumatic diseases (2019)
In patients with early RA, although TCZ-based strategies resulted in better DAS28 and remission rates compared with MTX+pred, at least part of these effects may be due to a specific effect of TCZ on APRs.